1. Downregulation of PPA2 expression correlates with poor prognosis of kidney renal clear cell carcinoma
   Wenbiao Zhu et al, 2021, PeerJ CrossRef
2. Identification and validation of an immune signature associated with EMT and metabolic reprogramming for predicting prognosis and drug response in bladder cancer
   Zhao Zhang et al, 2022, Frontiers in Immunology CrossRef
3. Studying the Metabolism of Epithelial-Mesenchymal Plasticity Using the Seahorse XFe96 Extracellular Flux Analyzer
   Sugandha Bhatia et al, 2021, The Epithelial-to Mesenchymal Transition CrossRef
4. Extracellular Vesicle-Mediated Chemoresistance in Oral Squamous Cell Carcinoma
   Zhu-Jun Law et al, 2021, Frontiers in Molecular Biosciences CrossRef
5. Crosstalk between Immune Checkpoint Modulators, Metabolic Reprogramming and Cellular Plasticity in Triple-Negative Breast Cancer
   Arpita Poddar et al, 2022, Current Oncology CrossRef
6. Risk factors for lymph node metastasis in superficial esophageal squamous cell carcinoma
   Yan-Bo Yu, 2024, World Journal of Gastroenterology CrossRef
7. UDP‐glucose dehydrogenase expression is upregulated following EMT and differentially affects intracellular glycerophosphocholine and acetylaspartate levels in breast mesenchymal cell lines
   Qiong Wang et al, 2022, Molecular Oncology CrossRef